CG Oncology, Inc.

CGON · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
40
SEC Filings

Business Summary

4 Item 1A. Risk Factors 38 Item 1B. Unresolved Staff Comments 101 Item 1C. Cybersecurity 101 Item 2. Properties 102 Item 3. Legal Proceedings 102 Item 4. Mine Safety Disclosures 103 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 104 Item 6. [Reserved] 106 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 107 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 12...

Next Earnings

Q2 FY2026 — expected 2026-09-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCGONdiscussed_in_filing Cybersecurity
topic_mentionCGONdiscussed_in_filing Cybersecurity
topic_mentionCGONdiscussed_in_filing Cybersecurity
topic_mentionCGONdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001193125-26-079498EDGAR98K words
2025-03-282024-12-310000950170-25-046351EDGAR—
2024-03-262023-12-310000950170-24-036143EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-283000EDGAR25K words
2025-08-082025-06-300000950170-25-105855EDGAR—
2025-05-132025-03-310000950170-25-069831EDGAR—
2024-11-122024-09-300000950170-24-124642EDGAR—
2024-08-082024-06-300000950170-24-093238EDGAR—
2024-05-092024-03-310000950170-24-056196EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-270001193125-26-079452EDGAR2K words
2026-01-130001193125-26-011855EDGAR—
2026-01-090001193125-26-008329EDGAR—
2025-11-260001193125-25-298160EDGAR—
2025-11-140001193125-25-283108EDGAR—
2025-11-140001193125-25-281672EDGAR—
2025-09-090001991792-25-000007EDGAR—
2025-09-050001991792-25-000004EDGAR—
2025-08-080000950170-25-105487EDGAR—
2025-07-110000950170-25-095296EDGAR—

40 total filings indexed. 21 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001991792
TickerCGON
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 4ec2f6db9e019e51b3b4ec107a638f330879b176b514fb63dce8632816c2c3d6
parent: 021801858e7d919048c13b6a9c0ebfef2f7cf0aba492c06ee3e4527175afcb2e
content hash: 8fbe1987915dbefeeea5ff2b16ce48cdd0415457c8acae0c283271c1da5cb13c
signed: 2026-04-13T04:44:17.902Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf